Clinical and Translational Allergy

Papers
(The H4-Index of Clinical and Translational Allergy is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Is diet partly responsible for differences in COVID-19 death rates between and within countries?90
Non‐specific lipid‐transfer proteins: Allergen structure and function, cross‐reactivity, sensitization, and epidemiology67
Male sex is strongly associated with IgE-sensitization to airborne but not food allergens: results up to age 24 years from the BAMSE birth cohort52
Worldwide prevalence of rhinitis in adults: A review of definitions and temporal evolution50
Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies50
Distinct type 2-high inflammation associated molecular signatures of chronic rhinosinusitis with nasal polyps with comorbid asthma38
AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer—a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)37
IgE autoantibodies and autoreactive T cells and their role in children and adults with atopic dermatitis34
Initiating pollen sensitization – complex source, complex mechanisms33
Molecular approach to a patient’s tailored diagnosis of the oral allergy syndrome32
Patients with suspected allergic reactions to COVID‐19 vaccines can be safely revaccinated after diagnostic work‐up30
Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study30
Fungal and bacterial microbiome dysbiosis and imbalance of trans-kingdom network in asthma30
Respiratory diseases and allergy in farmers working with livestock: a EAACI position paper29
Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK‐air®29
Anaphylactic risk related to omalizumab, benralizumab, reslizumab, mepolizumab, and dupilumab27
The applications of eHealth technologies in the management of asthma and allergic diseases27
Allergy to polyethylene glycol and polysorbates in a patient cohort: Diagnostic work‐up and decision points for vaccination during the COVID‐19 pandemic26
Genomics of asthma, allergy and chronic rhinosinusitis: novel concepts and relevance in airway mucosa26
Role of IL‐17 in atopy—A systematic review24
ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy23
Epinephrine delivery via EpiPen® Auto-Injector or manual syringe across participants with a wide range of skin-to-muscle distances23
Long‐term safety and effectiveness of berotralstat for hereditary angioedema: The open‐label APeX‐S study22
0.035422801971436